{"id":2234,"date":"2022-03-23T00:00:00","date_gmt":"2022-03-23T00:00:00","guid":{"rendered":"http:\/\/centogene.vl22350.dinaserver.com\/2234"},"modified":"2022-03-23T00:00:00","modified_gmt":"2022-03-23T00:00:00","slug":"centogene-anunciara-los-resultados-financieros-del-cuarto-trimestre-y-del-ano-fiscal-2021-el-30-de-marzo-de-2022","status":"publish","type":"post","link":"https:\/\/www.centogene.com\/es\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/","title":{"rendered":"CENTOGENE anunciar\u00e1 los resultados financieros del cuarto trimestre y del a\u00f1o fiscal 2021 el 30 de marzo de 2022"},"content":{"rendered":"

CAMBRIDGE, Massachusetts y ROSTOCK, Alemania, y BERL\u00cdN, 23 de marzo de 2022 (GLOBE NEWSWIRE) \u2013 Centogene NV (Nasdaq: CNTG), una empresa en fase comercial centrada en la generaci\u00f3n de informaci\u00f3n basada en datos para diagnosticar, comprender y tratar enfermedades raras, anunci\u00f3 hoy que publicar\u00e1 sus resultados financieros para el trimestre y el a\u00f1o completo finalizados el 31 de diciembre de 2021, el mi\u00e9rcoles 30 de marzo de 2022, y organizar\u00e1 una conferencia telef\u00f3nica y una transmisi\u00f3n web para analizar estos resultados a las 2 p. m. CEST \/ 8 a. m. EDT de ese d\u00eda.<\/p>\n

Los participantes pueden registrarse con antelaci\u00f3n para la conferencia telef\u00f3nica y la transmisi\u00f3n web que se realizar\u00e1 el 30 de marzo de 2022 en http:\/\/emea.directeventreg.com\/registration\/5737758<\/a>.<\/p>\n

Al registrarse, cada participante recibir\u00e1 un n\u00famero de acceso telef\u00f3nico, una contrase\u00f1a directa al evento y un ID de registro \u00fanico. Los participantes podr\u00e1n unirse hasta 10 minutos antes del inicio de la llamada.<\/p>\n

La transmisi\u00f3n web de la conferencia telef\u00f3nica y la presentaci\u00f3n de diapositivas tambi\u00e9n estar\u00e1n disponibles en la p\u00e1gina de Relaciones con los inversores del sitio web de la empresa en http:\/\/investors.centogene.com<\/a>.<\/p>\n

Acerca de CENTOGENE<\/h4>\n

CENTOGENE se dedica al diagn\u00f3stico y la investigaci\u00f3n de enfermedades raras, transformando datos cl\u00ednicos, gen\u00e9ticos y multi\u00f3micos del mundo real para diagnosticar, comprender y tratar enfermedades raras. Nuestro objetivo es racionalizar las decisiones terap\u00e9uticas y acelerar el desarrollo de nuevos medicamentos hu\u00e9rfanos mediante nuestro amplio conocimiento y datos sobre enfermedades raras. CENTOGENE ha desarrollado una plataforma global propia para enfermedades raras basada en nuestro repositorio de datos del mundo real de m\u00e1s de 600.000 pacientes de m\u00e1s de 120 pa\u00edses.<\/p>\n

La plataforma de la Compa\u00f1\u00eda incluye datos epidemiol\u00f3gicos, fenot\u00edpicos y gen\u00e9ticos que reflejan una poblaci\u00f3n global, as\u00ed como un biobanco de muestras de sangre y cultivos celulares de pacientes. CENTOGENE considera que esta es la \u00fanica plataforma centrada en el an\u00e1lisis exhaustivo de datos multinivel para mejorar la comprensi\u00f3n de las enfermedades hereditarias raras. Permite una mejor identificaci\u00f3n y estratificaci\u00f3n de los pacientes y sus enfermedades subyacentes para facilitar y acelerar el descubrimiento, el desarrollo y el acceso a medicamentos hu\u00e9rfanos. Al 31 de diciembre de 2020, la Compa\u00f1\u00eda colaboraba con m\u00e1s de 30 socios farmac\u00e9uticos.<\/p>\n

S\u00edguenos en LinkedIn<\/a><\/p>\n

Declaraciones prospectivas<\/h4>\n

Este comunicado de prensa contiene \u201cdeclaraciones prospectivas\u201d en el sentido de las leyes federales de valores de EE. UU. Las declaraciones aqu\u00ed contenidas que no sean claramente de naturaleza hist\u00f3rica se consideran prospectivas, y las palabras \u201canticipar\u201d, \u201ccreer\u201d, \u201ccontin\u00faa\u201d, \u201cesperar\u201d, \u201cestimar\u201d, \u201cpretender\u201d, \u201cproyectar\u201d y expresiones similares, as\u00ed como verbos en futuro o condicional como \u201cvoluntad\u201d, \u201cser\u00eda\u201d, \u201cdeber\u00eda\u201d, \u201cpodr\u00eda\u201d, \u201cpodr\u00eda\u201d, \u201cpuede\u201d y \u201cpuede\u201d, generalmente se utilizan para identificar declaraciones prospectivas. Dichas declaraciones prospectivas implican riesgos conocidos y desconocidos, incertidumbres y otros factores importantes que podr\u00edan causar que los resultados, el rendimiento o los logros reales de CENTOGENE difieran sustancialmente de cualquier resultado, rendimiento o logro futuro, expresado o impl\u00edcito en las declaraciones prospectivas. Tales riesgos e incertidumbres incluyen, entre otros, condiciones econ\u00f3micas mundiales negativas y la inestabilidad y volatilidad continuas en los mercados financieros mundiales, los efectos de la pandemia de COVID-19 en nuestro negocio y resultados de operaciones, posibles cambios en la legislaci\u00f3n actual y propuesta, regulaciones y pol\u00edticas gubernamentales, presiones de la creciente competencia y consolidaci\u00f3n en nuestra industria, el gasto y la incertidumbre de la aprobaci\u00f3n regulatoria, incluida la de la Administraci\u00f3n de Alimentos y Medicamentos de los EE. UU., nuestra dependencia de terceros y socios de colaboraci\u00f3n, incluida nuestra capacidad para gestionar el crecimiento y entablar nuevas relaciones con los clientes, nuestra dependencia de la industria de enfermedades raras, nuestra capacidad para gestionar la expansi\u00f3n internacional, nuestra dependencia del personal clave, nuestra dependencia de la protecci\u00f3n de la propiedad intelectual, fluctuaciones de nuestros resultados operativos debido al efecto de los tipos de cambio, nuestra capacidad para optimizar el uso de efectivo, nuestro requisito de financiamiento adicional y nuestra capacidad para continuar como un negocio en marcha, u otros factores. Para obtener m\u00e1s informaci\u00f3n sobre los riesgos e incertidumbres que podr\u00edan causar que los resultados reales difieran de los expresados en estas declaraciones prospectivas, as\u00ed como sobre los riesgos relacionados con el negocio de CENTOGENE en general, consulte los factores de riesgo de CENTOGENE establecidos en el Formulario 20-F presentado el 15 de abril de 2021 ante la Comisi\u00f3n de Bolsa y Valores (la "SEC") y en los documentos presentados posteriormente ante la SEC. Las declaraciones prospectivas contenidas en este comunicado de prensa se refieren \u00fanicamente a la fecha del presente, y CENTOGENE renuncia espec\u00edficamente a cualquier obligaci\u00f3n de actualizarlas, ya sea como resultado de nueva informaci\u00f3n, eventos futuros o cualquier otra causa.<\/p>\n

Contacto de prensa:  <\/h5>\n

CENTOGENE
Ben Legg
Comunicaciones corporativas 
presione(at)centogene(dot)com<\/a><\/p>\n

Lennart Streibel
Relaciones con los inversores
relacionesconinversores@centogene.com <\/a><\/p>\n

Stern IR  
Brendan Payne
+1 (212) 698 8695
brendan.payne@sternir.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

Centogene NV (Nasdaq: CNTG), una empresa en fase comercial centrada en generar informaci\u00f3n basada en datos para diagnosticar, comprender y tratar enfermedades raras, anunci\u00f3 hoy que publicar\u00e1 sus resultados financieros para el trimestre y el a\u00f1o completo finalizados el 31 de diciembre de 2021, el mi\u00e9rcoles 30 de marzo de 2022, y organizar\u00e1 una conferencia telef\u00f3nica y una transmisi\u00f3n web para analizar estos resultados a las 2:00 p. m. CEST \/ 8:00 a. m. EDT ese d\u00eda.<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-2234","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"\nCENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022 | CENTOGENE<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.centogene.com\/es\/centogene-anunciara-los-resultados-financieros-del-cuarto-trimestre-y-del-ano-fiscal-2021-el-30-de-marzo-de-2022\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022 | CENTOGENE\" \/>\n<meta property=\"og:description\" content=\"Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it will issue its financial results for the quarter and full year ended December 31, 2021, on Wednesday, March 30, 2022, and will host a conference call and webcast to discuss these results at 2 p.m. CEST \/ 8 a.m. EDT that day.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.centogene.com\/es\/centogene-anunciara-los-resultados-financieros-del-cuarto-trimestre-y-del-ano-fiscal-2021-el-30-de-marzo-de-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"CENTOGENE\" \/>\n<meta property=\"article:published_time\" content=\"2022-03-23T00:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"740\" \/>\n\t<meta property=\"og:image:height\" content=\"416\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admincg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admincg\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\\\/\"},\"author\":{\"name\":\"admincg\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\"},\"headline\":\"CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022\",\"datePublished\":\"2022-03-23T00:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\\\/\"},\"wordCount\":721,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\\\/\",\"name\":\"CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022 | CENTOGENE\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\"},\"datePublished\":\"2022-03-23T00:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.centogene.com\\\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.centogene.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#website\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"name\":\"CENTOGENE\",\"description\":\"Guiding Precision Medicine\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.centogene.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#organization\",\"name\":\"CENTOGENE\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"contentUrl\":\"https:\\\/\\\/www.centogene.com\\\/wp-content\\\/uploads\\\/2026\\\/04\\\/CENTOGENE-Flower.png\",\"width\":246,\"height\":246,\"caption\":\"CENTOGENE\"},\"image\":{\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.linkedin.com\\\/company\\\/centogene\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UClZxtN_laC1_ZtCdxkasdPQ\",\"https:\\\/\\\/www.instagram.com\\\/_centogene_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.centogene.com\\\/#\\\/schema\\\/person\\\/d9b8738539a9ddb5de5a02a909d40b8b\",\"name\":\"admincg\",\"url\":\"https:\\\/\\\/www.centogene.com\\\/es\\\/author\\\/admincg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"CENTOGENE anunciar\u00e1 los resultados financieros del cuarto trimestre y del a\u00f1o fiscal 2021 el 30 de marzo de 2022 | CENTOGENE","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.centogene.com\/es\/centogene-anunciara-los-resultados-financieros-del-cuarto-trimestre-y-del-ano-fiscal-2021-el-30-de-marzo-de-2022\/","og_locale":"es_ES","og_type":"article","og_title":"CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022 | CENTOGENE","og_description":"Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced that it will issue its financial results for the quarter and full year ended December 31, 2021, on Wednesday, March 30, 2022, and will host a conference call and webcast to discuss these results at 2 p.m. CEST \/ 8 a.m. EDT that day.","og_url":"https:\/\/www.centogene.com\/es\/centogene-anunciara-los-resultados-financieros-del-cuarto-trimestre-y-del-ano-fiscal-2021-el-30-de-marzo-de-2022\/","og_site_name":"CENTOGENE","article_published_time":"2022-03-23T00:00:00+00:00","og_image":[{"width":740,"height":416,"url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2025\/03\/csm_centogene-diagnostics-priority-disease-03_5a57c07603.webp","type":"image\/webp"}],"author":"admincg","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admincg","Tiempo de lectura":"4 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.centogene.com\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/#article","isPartOf":{"@id":"https:\/\/www.centogene.com\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/"},"author":{"name":"admincg","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b"},"headline":"CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022","datePublished":"2022-03-23T00:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.centogene.com\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/"},"wordCount":721,"commentCount":0,"publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.centogene.com\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.centogene.com\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/","url":"https:\/\/www.centogene.com\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/","name":"CENTOGENE anunciar\u00e1 los resultados financieros del cuarto trimestre y del a\u00f1o fiscal 2021 el 30 de marzo de 2022 | CENTOGENE","isPartOf":{"@id":"https:\/\/www.centogene.com\/#website"},"datePublished":"2022-03-23T00:00:00+00:00","breadcrumb":{"@id":"https:\/\/www.centogene.com\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.centogene.com\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.centogene.com\/centogene-to-announce-fourth-quarter-and-fiscal-year-2021-financial-results-on-march-30-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.centogene.com\/"},{"@type":"ListItem","position":2,"name":"CENTOGENE to Announce Fourth Quarter and Fiscal Year 2021 Financial Results on March 30, 2022"}]},{"@type":"WebSite","@id":"https:\/\/www.centogene.com\/#website","url":"https:\/\/www.centogene.com\/","name":"CENTOGENE","description":"Impulsar la medicina de precisi\u00f3n","publisher":{"@id":"https:\/\/www.centogene.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.centogene.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.centogene.com\/#organization","name":"CENTOGENE","url":"https:\/\/www.centogene.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/","url":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","contentUrl":"https:\/\/www.centogene.com\/wp-content\/uploads\/2026\/04\/CENTOGENE-Flower.png","width":246,"height":246,"caption":"CENTOGENE"},"image":{"@id":"https:\/\/www.centogene.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/centogene","https:\/\/www.youtube.com\/channel\/UClZxtN_laC1_ZtCdxkasdPQ","https:\/\/www.instagram.com\/_centogene_\/"]},{"@type":"Person","@id":"https:\/\/www.centogene.com\/#\/schema\/person\/d9b8738539a9ddb5de5a02a909d40b8b","name":"administrador","url":"https:\/\/www.centogene.com\/es\/author\/admincg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2234","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/comments?post=2234"}],"version-history":[{"count":0,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/posts\/2234\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/media?parent=2234"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/categories?post=2234"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.centogene.com\/es\/wp-json\/wp\/v2\/tags?post=2234"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}